Zobrazeno 31 - 40
of 76
pro vyhledávání: '"Daniela Di Giuseppe"'
Autor:
Michael Nissen, Bénédicte Delcoigne, Daniela Di Giuseppe, Lennart Jacobsson, Merete Lund Hetland, Adrian Ciurea, Lucie Nekvindova, Florenzo Iannone, Nurullah Akkoc, Tuulikki Sokka-Isler, Karen Minde Fagerli, Maria Jose Santos, Catalin Codreanu, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Irene van der Horst-Bruinsma, Anne Gitte Loft, Burkhard Möller, Herman Mann, Fabrizio Conti, Gozde Yildirim Cetin, Heikki Relas, Brigitte Michelsen, Pedro Avila Ribeiro, Ruxandra Ionescu, Carlos Sanchez-Piedra, Matija Tomsic, Árni Jón Geirsson, Johan Askling, Bente Glintborg, Ulf Lindström
Publikováno v:
Rheumatology, 61, 12, pp. 4741-4751
Nissen, M, Delcoigne, B, Di Giuseppe, D, Jacobsson, L, Hetland, M L, Ciurea, A, Nekvindova, L, Iannone, F, Akkoc, N, Sokka-Isler, T, Fagerli, K M, Santos, M J, Codreanu, C, Pombo-Suarez, M, Rotar, Z, Gudbjornsson, B, van der Horst-Bruinsma, I, Loft, A G, Möller, B, Mann, H, Conti, F, Yildirim Cetin, G, Relas, H, Michelsen, B, Avila Ribeiro, P, Ionescu, R, Sanchez-Piedra, C, Tomsic, M, Geirsson, Á J, Askling, J, Glintborg, B & Lindström, U 2022, ' The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis ', Rheumatology, vol. 61, no. 12, pp. 4741-4751 . https://doi.org/10.1093/rheumatology/keac174
Nissen, M, Delcoigne, B N, di Giuseppe, D, Jacobsson, L, Hetland, M L, Ciurea, A, Nekvindova, L, Iannone, F, Akkoc, N, Sokka-Isler, T, Fagerli, K M, Santos, M J, Codreanu, C, Pombo-Suarez, M, Rotar, Z, Gudbjornsson, B, van der Horst-Bruinsma, I, Loft, A G, Möller, B, Mann, H, Conti, F, Yildirim Cetin, G, Relas, H, Michelsen, B, Avila Ribeiro, P, Ionescu, R, Sanchez-Piedra, C, Tomsic, M, Geirsson, Á J N, Askling, J, Glintborg, B & Lindström, U 2022, ' The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis ', Rheumatology (Oxford, England), vol. 61, no. 12, pp. 4741-4751 . https://doi.org/10.1093/rheumatology/keac174
Rheumatology (Oxford, England), 61(12), 4741-4751. Oxford University Press
Nissen, Michael; Delcoigne, Bénédicte; Di Giuseppe, Daniela; Jacobsson, Lennart; Hetland, Merete Lund; Ciurea, Adrian; Nekvindova, Lucie; Iannone, Florenzo; Akkoc, Nurullah; Sokka-Isler, Tuulikki; Fagerli, Karen Minde; Santos, Maria Jose; Codreanu, Catalin; Pombo-Suarez, Manuel; Rotar, Ziga; Gudbjornsson, Bjorn; van der Horst-Bruinsma, Irene; Loft, Anne Gitte; Möller, Burkhard; Mann, Herman; ... (2022). The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis. Rheumatology, 61(12), pp. 4741-4751. Oxford University Press 10.1093/rheumatology/keac174
Rheumatology, 61, 4741-4751
Nissen, M, Delcoigne, B, Di Giuseppe, D, Jacobsson, L, Hetland, M L, Ciurea, A, Nekvindova, L, Iannone, F, Akkoc, N, Sokka-Isler, T, Fagerli, K M, Santos, M J, Codreanu, C, Pombo-Suarez, M, Rotar, Z, Gudbjornsson, B, van der Horst-Bruinsma, I, Loft, A G, Möller, B, Mann, H, Conti, F, Yildirim Cetin, G, Relas, H, Michelsen, B, Avila Ribeiro, P, Ionescu, R, Sanchez-Piedra, C, Tomsic, M, Geirsson, Á J, Askling, J, Glintborg, B & Lindström, U 2022, ' The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis ', Rheumatology, vol. 61, no. 12, pp. 4741-4751 . https://doi.org/10.1093/rheumatology/keac174
Nissen, M, Delcoigne, B N, di Giuseppe, D, Jacobsson, L, Hetland, M L, Ciurea, A, Nekvindova, L, Iannone, F, Akkoc, N, Sokka-Isler, T, Fagerli, K M, Santos, M J, Codreanu, C, Pombo-Suarez, M, Rotar, Z, Gudbjornsson, B, van der Horst-Bruinsma, I, Loft, A G, Möller, B, Mann, H, Conti, F, Yildirim Cetin, G, Relas, H, Michelsen, B, Avila Ribeiro, P, Ionescu, R, Sanchez-Piedra, C, Tomsic, M, Geirsson, Á J N, Askling, J, Glintborg, B & Lindström, U 2022, ' The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis ', Rheumatology (Oxford, England), vol. 61, no. 12, pp. 4741-4751 . https://doi.org/10.1093/rheumatology/keac174
Rheumatology (Oxford, England), 61(12), 4741-4751. Oxford University Press
Nissen, Michael; Delcoigne, Bénédicte; Di Giuseppe, Daniela; Jacobsson, Lennart; Hetland, Merete Lund; Ciurea, Adrian; Nekvindova, Lucie; Iannone, Florenzo; Akkoc, Nurullah; Sokka-Isler, Tuulikki; Fagerli, Karen Minde; Santos, Maria Jose; Codreanu, Catalin; Pombo-Suarez, Manuel; Rotar, Ziga; Gudbjornsson, Bjorn; van der Horst-Bruinsma, Irene; Loft, Anne Gitte; Möller, Burkhard; Mann, Herman; ... (2022). The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis. Rheumatology, 61(12), pp. 4741-4751. Oxford University Press 10.1093/rheumatology/keac174
Rheumatology, 61, 4741-4751
Objectives Many axial spondylarthritis (axSpA) patients receive a conventional synthetic DMARD (csDMARD) in combination with a TNF inhibitor (TNFi). However, the value of this co-therapy remains unclear. The objectives were to describe the characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20aa85f05662083b702b6507faf3bb4
https://repository.ubn.ru.nl/handle/2066/287602
https://repository.ubn.ru.nl/handle/2066/287602
Autor:
Bénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, Daniela Di Giuseppe, Thomas Frisell, Bente Glintborg, Gerdur Grondal, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Dan Nordström, Heikki Relas, Johan Askling
Publikováno v:
Delcoigne, B, Provan, S A, Hammer, H B, Di Giuseppe, D, Frisell, T, Glintborg, B, Grondal, G, Gudbjornsson, B, Hetland, M L, Michelsen, B, Nordström, D, Relas, H & Askling, J 2022, ' Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration ', Rheumatology, vol. 61, no. 11, pp. 4286-4296 . https://doi.org/10.1093/rheumatology/keac081
Objectives To investigate whether patient-reported outcomes vary across countries and are influenced by cultural/contextual factors. Specifically, we aimed to assess inter-country differences in tender joint count (TJC), pain and patient’s global h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c821933be0e89de8300b52e57ad3b7
https://curis.ku.dk/portal/da/publications/do-patientreported-measures-of-disease-activity-in-rheumatoid-arthritis-vary-between-countries-results-from-a-nordic-collaboration(ea0fc789-a21b-4f7e-b018-5333bd6524b0).html
https://curis.ku.dk/portal/da/publications/do-patientreported-measures-of-disease-activity-in-rheumatoid-arthritis-vary-between-countries-results-from-a-nordic-collaboration(ea0fc789-a21b-4f7e-b018-5333bd6524b0).html
Autor:
Helga Westerlind, Justine Dukuzimana, Xiaomin Lu, Lars Alfredsson, Lars Klareskog, Daniela Di Giuseppe
Publikováno v:
Arthritis researchtherapy. 24(1)
Background Studies on the association between coffee, a modifiable lifestyle factor, and rheumatoid arthritis (RA), a chronic autoimmune disease primarily affecting the joints, have been conflicting. The aim of the present study was to study the asso
Autor:
Johan Askling, Christer Sundström, Karin E. Smedby, Daniela Di Giuseppe, Eva Baecklund, Karin Hellgren
Publikováno v:
Rheumatology. 60:809-819
Objectives To estimate the association between biological DMARDs (bDMARDs; overall and by drug) as used in RA and the risk of malignant lymphomas including subtypes. Methods By linking nationwide Swedish registers we identified cohorts of patients wi
Autor:
Anders Eklund, Daniela Di Giuseppe, Johan Askling, Susanna Kullberg, Elizabeth V. Arkema, Johan Grunewald, Marios Rossides
Publikováno v:
European Journal of Epidemiology
Findings from molecular studies suggesting that several infectious agents cause sarcoidosis are intriguing yet conflicting and likely biased due to their cross-sectional design. As done in other inflammatory diseases to overcome this issue, prospecti
Autor:
Daniela Di Giuseppe, Ulf Lindstrom, Hannah Bower, Bénédicte Delcoigne, Thomas Frisell, Katerina Chatzidionysiou, Christopher Sjöwall, Elisabet Lindqvist, Johan Askling
Publikováno v:
Rheumatology (Oxford, England). 61(9)
Objectives To compare treatment retention between biosimilars and their originator products among first starters (etanercept, infliximab, adalimumab and rituximab), as well as after non-medical switch. Methods Patients with rheumatic diseases startin
Autor:
Bénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, Daniela Di Giuseppe, Thomas Frisell, Bente Glintborg, Gerdur Grondal, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Dan Nordström, Heikki Relas, Johan Askling
Publikováno v:
Rheumatology. 61:4998-4998
Autor:
Dan Nordström, Tore K Kvien, Lene Dreyer, Nina Trokovic, Karin Hellgren, Katerina Chatzidionysiou, Tanja Schjødt Jørgensen, Gerdur Grondal, Daniela Di Giuseppe, Sella Aarrestad Provan, Thomas Frisell, Lennart T H Jacobsson, Bjorn Gudbjornsson, Johan Askling, Lars Erik Kristensen, Eirik Kristianslund, Kalle Aaltonen, Merete Lund Hetland, Ritva Peltomaa, Bente Glintborg
Publikováno v:
Chatzidionysiou, K, Hetland, M L, Frisell, T, Di Giuseppe, D, Hellgren, K, Glintborg, B, Nordström, D, Peltomaa, R, Aaltonen, K, Trokovic, N, Kristianslund, E K, Kvien, T K, Provan, S A, Gudbjornsson, B, Grondal, G, Dreyer, L, Kristensen, L E, Jørgensen, T S, Jacobsson, L T H & Askling, J 2021, ' Effectiveness of a second biologic after failure of a non-tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis ', Journal of Rheumatology, vol. 48, no. 10, jrheum.201467, pp. 1512-1518 . https://doi.org/10.3899/jrheum.201467
ObjectiveIn rheumatoid arthritis (RA), evidence regarding the effectiveness of a second biologic disease-modifying antirheumatic drug (bDMARD) in patients whose first-ever bDMARD was a non–tumor necrosis factor inhibitor (TNFi) bDMARD is limited. T
Autor:
Katerina Chatzidionysiou, Helena Forsblad-d'Elia, Christopher Sjöwall, Hannah Bower, Carl Turesson, Lars Klareskog, Daniela Di Giuseppe, Johan Askling, Gerd-Marie Ahlenius, Eva Baecklund, Thomas Frisell, Elisabet Lindqvist, Alf Kastbom, Bénédicte Delcoigne, Ulf Lindström, Nils Feltelius
Publikováno v:
Annals of the Rheumatic Diseases
Objectives To estimate absolute and relative risks for all-cause mortality and for severe COVID-19 in inflammatory joint diseases (IJDs) and with antirheumatic therapies. Methods Through Swedish nationwide multiregister linkages, we selected all adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bb0ce257918b1b132775a1d9a79efed
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181536
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181536
Autor:
Irene E. van der Horst-Bruinsma, Manuel Pombo-Suarez, Tore K Kvien, Helena Santos, Johan K. Wallman, Sema Yilmaz, Ruxandra Ionescu, Lucie Nekvindová, Nina Trokovic, Kari K. Eklund, Maria José Santos, Ennio Giulio Favalli, Bjorn Gudbjornsson, Stylianos Georgiadis, Gareth T. Jones, Yavuz Pehlivan, Merete Lund Hetland, Florenzo Iannone, Carlos Sánchez-Piedra, Catalin Codreanu, Eirik Kristianslund, Anne Gitte Loft, Daniela Di Giuseppe, Ziga Rotar, Matija Tomšič, Brigitte Michelsen, Mikkel Østergaard, Burkhard Möller, Lykke Midtbøll Ørnbjerg, Michael John Nissen, Cecilie Heegaard Brahe, Herman Mann, Thorvardur Jon Love
Publikováno v:
Michelsen, B, Georgiadis, S, Di Giuseppe, D, Loft, A G, Nissen, M J, Iannone, F, Pombo-Suarez, M, Mann, H, Rotar, Z, Eklund, K K, Kvien, T K, Santos, M J, Gudbjornsson, B, Codreanu, C, Yilmaz, S, Wallman, J K, Brahe, C H, Möller, B, Favalli, E G, Sánchez-Piedra, C, Nekvindova, L, Tomsic, M, Trokovic, N, Kristianslund, E K, Santos, H, Löve, T J, Ionescu, R, Pehlivan, Y, Jones, G T, van der Horst-Bruinsma, I, Ørnbjerg, L M, Østergaard, M & Hetland, M L 2022, ' Real-World Six-and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries ', Arthritis Care and Research, vol. 74, no. 7, pp. 1205-1218 . https://doi.org/10.1002/acr.24560
Arthritis Care & Research, 74, 7, pp. 1205-1218
Arthritis Care & Research, 74, 1205-1218
Arthritis Care & Research, 74, 7, pp. 1205-1218
Arthritis Care & Research, 74, 1205-1218
Contains fulltext : 251829.pdf (Publisher’s version ) (Open Access) OBJECTIVE: There is a lack of real-life studies on interleukin-17 (IL-17) inhibition in psoriatic arthritis (PsA). We assessed real-life 6- and 12-month effectiveness (i.e., retent